biopharmaceutic ivive informed pbpk model of ritonavir norvir
Published 4 years ago • 921 plays • Length 1:30:54Download video MP4
Download video MP3
Similar videos
-
50:55
pbpk modelling of in vitro skin permeation & ivive for topically applied metronidazole
-
59:49
pbpk modeling approaches to assess risks associated with bioequivalence in drug development
-
55:43
pbpk modelling to predict drug-biologic interactions with cytokine modulators
-
1:06:27
the importance of pbpk model validation and reproducibility in obstetric pharmacology
-
1:01:14
pbpk modeling & simulation to support asciminib nda submission and inform drug product label
-
49:08
achieving virtual bioequivalence with pbpk in lieu of clinical studies
-
58:36
pbpk for the pill an approach to assess the risk benefit of drugs
-
1:02
biopharmaceutical industry & ireland 2019
-
59:23
first-in-human (fih) faster: the power of physiologically based pharmacokinetic (pbpk) modeling
-
0:52
mayo clinic platform_accelerate: biotia
-
1:52
epitopes and biopharmaceuticals
-
3:26
fondazione ri.med 360 animation v2